BIOLASE Market Cap

BIOLASE has a market cap or net worth of $2.29 million as of July 22, 2024. Its market cap has decreased by -0.25% in one year.

Market Cap

2.29M

Enterprise Value

13.56M

1-Year Change

-0.25%

Ranking

n/a

Market Cap Chart

Since December 1, 1998, BIOLASE's market cap has decreased from $42.20M to $2.29M, a decrease of -94.56%. That is a compound annual growth rate of -10.77%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2024	4.30M	65.38%
Dec 29, 2023	2.60M	-43.48%
Dec 30, 2022	4.60M	-92.31%
Dec 31, 2021	59.80M	54.12%
Dec 31, 2020	38.80M	126.90%
Dec 31, 2019	17.10M	-16.18%
Dec 31, 2018	20.40M	-37.04%
Dec 29, 2017	32.40M	-65.75%
Dec 30, 2016	94.60M	93.06%
Dec 31, 2015	49.00M	-57.61%
Dec 31, 2014	115.60M	16.65%
Dec 31, 2013	99.10M	71.16%
Dec 31, 2012	57.90M	-26.43%
Dec 30, 2011	78.70M	83.02%
Dec 31, 2010	43.00M	-7.53%
Dec 31, 2009	46.50M	28.81%
Dec 31, 2008	36.10M	-35.99%
Dec 31, 2007	56.40M	-72.78%
Dec 29, 2006	207.20M	11.58%
Dec 30, 2005	185.70M	-24.88%
Dec 31, 2004	247.20M	-30.89%
Dec 31, 2003	357.70M	224.89%
Dec 31, 2002	110.10M	-1.52%
Dec 31, 2001	111.80M	233.73%
Dec 29, 2000	33.50M	-29.77%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	814.94B
Novo Nordisk	579.91B
UnitedHealth Group	520.32B
Johnson & Johnson	372.29B
Merck & Co.	318.55B
AbbVie	304.29B
AstraZeneca	244.04B
Novartis AG	207.64B

Market Cap Rankings